dvt - Nursing Case Study
Pathophysiology
• Primary mechanism: Venous stasis occurs when blood flow slows down in the deep veins, often due to prolonged immobility, leading to increased risk of clot formation as the normal blood flow that prevents clotting is disrupted.
• Secondary mechanism: Hypercoagulability is a state where the blood has an increased tendency to clot, which can be triggered by factors such as surgery, cancer, pregnancy, or genetic predispositions, further contributing to the risk of DVT.
• Key complication: If the clot dislodges, it can travel to the lungs, causing a pulmonary embolism, a life-threatening condition characterized by sudden chest pain, difficulty breathing, and reduced oxygenation of blood.
Patient Profile
Demographics:
45-year-old female, office worker
History:
• Key past medical history: History of smoking, hypertension, recent long-haul flight
• Current medications: Lisinopril, low-dose aspirin
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Swelling and pain in the left leg
• Key symptoms: Redness and warmth in the left calf, mild shortness of breath, occasional palpitations
• Vital signs: Blood pressure 150/95 mmHg, heart rate 110 bpm, respiratory rate 20 breaths per minute, temperature 99.1°F, oxygen saturation 93% on room air
Section 1
As the initial assessment progresses, the healthcare team conducts a Doppler ultrasound on the patient's left leg, confirming the presence of a deep vein thrombosis (DVT) in the popliteal vein. The patient's lab results further reveal elevated D-dimer levels, indicating a significant likelihood of clot formation. The combination of these findings, along with the patient's recent history of a long-haul flight and smoking, underscores the classic risk factors contributing to venous thromboembolism. The patient's blood work also shows a slight increase in white blood cell count, which may suggest an inflammatory response.
Shortly after these findings, the patient's condition begins to change. She complains of increased difficulty breathing and chest discomfort, prompting an urgent reassessment. Her vital signs show a heart rate of 120 bpm, respiratory rate of 28 breaths per minute, and an oxygen saturation dropping to 88% on room air. These changes raise the clinical suspicion of a pulmonary embolism (PE), a critical complication of DVT where the clot has potentially traveled to the lungs, obstructing blood flow and impairing oxygenation.
In response to this acute change, the medical team initiates supplemental oxygen therapy to address hypoxemia and prepares for immediate imaging studies, such as a CT pulmonary angiogram, to confirm the diagnosis of PE. Anticoagulation therapy is prioritized to stabilize the patient and prevent further clot propagation. The unfolding scenario requires the nursing team to apply clinical reasoning to closely monitor the patient's respiratory status, ensure timely administration of anticoagulants, and anticipate potential complications like hemodynamic instability, guiding the next steps of her treatment plan.
Section 2
As the healthcare team administers anticoagulation therapy and supplemental oxygen, the patient’s condition requires continuous monitoring. An hour into treatment, the patient’s heart rate further increases to 135 bpm, and her respiratory rate remains elevated at 30 breaths per minute, despite oxygen supplementation. Her blood pressure begins to show signs of instability, fluctuating between 90/60 mmHg and 85/50 mmHg, prompting concerns about hemodynamic compromise. Her oxygen saturation slightly improves to 92% with high-flow oxygen, but her level of consciousness is subtly altered, becoming increasingly drowsy and less responsive to questions.
In tandem with these observations, the results of the CT pulmonary angiogram confirm the presence of a significant pulmonary embolism in the right pulmonary artery. The size and location of the embolism suggest a substantial obstruction to pulmonary circulation, contributing to the patient's respiratory distress and potential right ventricular strain. Lab tests reveal elevated troponin levels, indicating myocardial strain secondary to PE. These findings necessitate careful consideration of potential thrombolytic therapy, especially given the patient's hemodynamic instability.
The nursing team must now prioritize interventions to stabilize the patient's condition. Close monitoring of vital signs, neurological status, and urine output is essential to detect signs of worsening shock or multiorgan involvement. Nurses must ensure timely communication with the interdisciplinary team to evaluate the appropriateness and timing of thrombolytics or other advanced interventions, such as catheter-directed thrombus removal. This critical phase demands robust clinical reasoning to assess the risks and benefits of aggressive treatment strategies while maintaining vigilant support for the patient's cardiopulmonary function.
Section 3
As the healthcare team closely monitors the patient, additional assessment findings reveal emerging complications that require immediate attention. The nursing team notices a further decline in the patient's neurological status; she is now only intermittently responsive to verbal stimuli and exhibits a Glasgow Coma Scale score of 10. Her skin appears cool and clammy, suggesting peripheral vasoconstriction and potential worsening of her hemodynamic status. The patient's heart rate has climbed to 145 bpm, and her respiratory rate remains elevated at 32 breaths per minute, despite high-flow oxygen therapy. Blood pressure readings continue to fluctuate, with the most recent measure at 82/48 mmHg, indicating possible progression to shock.
In response, the healthcare team initiates a focused reassessment of her cardiovascular and respiratory function. Arterial blood gas analysis reveals a pH of 7.28, PaCO2 of 55 mmHg, and PaO2 of 60 mmHg on high-flow oxygen, indicating worsening respiratory acidosis and hypoxemia. Repeat lab tests show a further rise in troponin levels, and the D-dimer remains elevated. The patient's urine output has decreased to 15 mL/hr, raising concerns about renal perfusion in the context of her low blood pressure and potential multiorgan involvement.
Given these changes, the interdisciplinary team convenes promptly to discuss the initiation of thrombolytic therapy to address the significant pulmonary embolism, weighing the urgency against bleeding risks. Concurrently, the nursing staff implements measures to manage the patient's hemodynamic instability, including fluid resuscitation and consideration of vasopressor support. The team remains vigilant, ready to escalate care, and continuously reassesses the patient's response to interventions, staying prepared for potential transfer to a higher level of care if her condition deteriorates further. This phase of the patient's journey underscores the importance of timely clinical decision-making and the need for a coordinated team approach to prevent further complications.
Section 4
As the healthcare team continues to closely monitor the patient, a change in her status becomes evident. Despite the initiation of thrombolytic therapy, her condition remains precarious. The patient's heart rate, initially high, begins to show irregularities, with episodes of atrial fibrillation interspersed with her tachycardia, suggesting cardiac stress or ischemia. Her blood pressure remains unstable despite aggressive fluid resuscitation, fluctuating between hypotensive readings of 78/45 mmHg and brief periods of relative improvement. The nursing staff notes that her skin remains cool and clammy, and capillary refill is delayed, indicating poor peripheral perfusion.
New diagnostic results provide further insights into the patient's condition. An echocardiogram reveals right ventricular strain, consistent with the significant burden of the pulmonary embolism on her heart. This finding correlates with the elevated troponin levels, pointing towards myocardial injury due to increased cardiac workload. Additionally, repeat arterial blood gas analysis shows persistent respiratory acidosis, with a pH of 7.26 and a PaCO2 now at 58 mmHg, underscoring the severity of her respiratory compromise. The PaO2 remains low at 57 mmHg, despite continued high-flow oxygen, suggesting that the thrombolytic therapy has yet to significantly improve pulmonary perfusion.
In light of these developments, the healthcare team deliberates on further escalation of care. They discuss the potential need for mechanical ventilation to address the patient's respiratory failure and consider the initiation of vasopressor support to stabilize her hemodynamic status, particularly given the inadequate response to fluid therapy. The interdisciplinary team remains poised to act swiftly, recognizing the critical window to prevent progression to multiorgan failure. This situation highlights the complexity of managing such cases, where timely interventions must be balanced with the risks inherent in the patient's fragile condition.
Section 5
As the healthcare team deliberates on the next steps, a new complication emerges. The patient begins to exhibit increasing respiratory distress, characterized by labored breathing and accessory muscle use. Her respiratory rate escalates to 32 breaths per minute, and she appears increasingly fatigued. The decision is made to initiate mechanical ventilation to support her compromised respiratory system. This intervention is undertaken carefully, with the team mindful of the potential hemodynamic consequences, given her unstable blood pressure.
Despite the initiation of mechanical ventilation, the patient's hemodynamic instability persists. Her blood pressure continues to fluctuate, with readings as low as 72/40 mmHg, prompting the team to start low-dose norepinephrine infusion to maintain adequate perfusion pressures. Nursing staff closely monitor her urine output, which has decreased to 15 mL/hr, raising concerns about renal perfusion and function. Laboratory tests reveal worsening renal indices, with creatinine levels rising to 2.3 mg/dL, indicating acute kidney injury secondary to impaired perfusion.
Concurrently, the team reviews her coagulation profile and notes a marked prolongation in her prothrombin time (PT) and activated partial thromboplastin time (aPTT), raising concerns about potential bleeding complications from the thrombolytic therapy. This necessitates a delicate balance between managing her clot burden and preventing bleeding. The interdisciplinary team discusses the possibility of transitioning to a more conservative anticoagulation strategy, considering her current clinical status and the risk of further complications. This decision-making process underscores the intricate balance of risks and benefits in the management of her evolving condition, as the team remains vigilant in monitoring for any signs of bleeding or further deterioration.